Alpha 2.0
Login Register
» Authors » Yaxian Huang

Yaxian Huang

Explore the profile of Yaxian Huang including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 8
Followers 0
Related Specialties
Chemistry
General Medicine
Cell Biology
Top 10 Co-Authors
Chi Zhan
Zhengmei Lin
Zhi Song
Jinyan Wu
Zhaocai Zhou
Shuyin Liang
Zhikun Liu
Xifeng Li
Chuang Wu
Guiyang Jiang
Published In
Eur J Med Chem
Front Pharmacol
Gastroenterol Rep (Oxf)
Cell Death Dis
iScience
Affiliations
Soon will be listed here.
Recent Articles
1.
Corrigendum to "Novel Platinum(IV) complexes intervene oxaliplatin resistance in colon cancer via inducing ferroptosis and apoptosis" [Eur. J. Med. Chem. 263 (2024) 115968]
Liu Z, Cai J, Jiang G, Wang M, Wu C, Su K, et al.
Eur J Med Chem . 2024 Oct; 280:116976. PMID: 39438194
No abstract available.
2.
Predictive value of the systemic immune-inflammation index for periprocedural complications in flow diverter treatment for patients with intracranial aneurysms
Huang J, Huang Y, Feng X, Huang C, Huang M, Wen Z, et al.
Neurosurg Rev . 2024 Oct; 47(1):809. PMID: 39436476
Flow-diverter devices (FDs) are effective in treating intracranial aneurysms (IAs) but carry substantial periprocedural risks, particularly ischemic complications. This study aimed to determine if elevated Systemic Immune-Inflammation Index (SII) can...
3.
Hepcidin depending on astrocytic NEO1 ameliorates blood-brain barrier dysfunction after subarachnoid hemorrhage
Wei B, Liu W, Jin L, Huang Y, Cheng W, Fan H, et al.
Cell Death Dis . 2024 Aug; 15(8):569. PMID: 39107268
Subarachnoid hemorrhage (SAH) significantly compromises the blood-brain barrier (BBB) and impairs patient recovery. This study elucidates the critical role of astrocytic Neogenin-1 (NEO1) in BBB integrity post-SAH and examines the...
4.
Novel Platinum(IV) complexes intervene oxaliplatin resistance in colon cancer via inducing ferroptosis and apoptosis
Liu Z, Cai J, Jiang G, Wang M, Wu C, Su K, et al.
Eur J Med Chem . 2023 Nov; 263:115968. PMID: 37995563
Platinum-based chemotherapeutics are widely used for cancer treatment but are frequently limited because of dosage-dependent side effects and drug resistance. To attenuate these drawbacks, a series of novel platinum(IV) prodrugs...
5.
Thioredoxin-1 promotes the restoration of alveolar bone in periodontitis with diabetes
Wu J, Huang Y, Zhan C, Chen L, Lin Z, Song Z
iScience . 2023 Sep; 26(9):107618. PMID: 37664614
Treatment of periodontitis in people with diabetes remains challenging. The present study aimed to investigate the therapeutic potential of thioredoxin-1 (TRX1) in periodontitis with diabetes, as well as its role...
6.
Exploration of the shared gene signatures and molecular mechanisms between periodontitis and inflammatory bowel disease: evidence from transcriptome data
Zhan C, Zhou Z, Huang Y, Huang S, Lin Z, He F, et al.
Gastroenterol Rep (Oxf) . 2023 Jul; 11:goad041. PMID: 37456714
Background: Periodontitis disease (PD) is associated with a systemic disorder of inflammatory bowel disease (IBD). The immune response is the common feature of the two conditions, but the more precise...
7.
TRAF-STOP alleviates osteoclastogenesis in periodontitis
Huang Y, Wu J, Zhan C, Liu R, Zhou Z, Huang X, et al.
Front Pharmacol . 2023 Jun; 14:1119847. PMID: 37261283
The enhanced osteoclastogenesis contributes to alveolar bone resorption in periodontitis, which increases the risk of tooth loss. To reduce bone destruction, the inhibition of osteoclast development is proposed as a...